Caprock Group LLC bought a new position in shares of Centene Corporation (NYSE:CNC – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 19,974 shares of the company’s stock, valued at approximately $713,000.
Other large investors have also recently made changes to their positions in the company. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in Centene in the third quarter valued at approximately $27,000. WPG Advisers LLC raised its holdings in shares of Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after buying an additional 282 shares during the period. Bogart Wealth LLC lifted its stake in Centene by 11,011.1% during the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after acquiring an additional 991 shares in the last quarter. Financial Network Wealth Advisors LLC boosted its holdings in Centene by 54.9% during the 3rd quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock valued at $39,000 after acquiring an additional 390 shares during the period. Finally, Assetmark Inc. increased its stake in Centene by 248.2% during the second quarter. Assetmark Inc. now owns 1,156 shares of the company’s stock worth $63,000 after purchasing an additional 824 shares during the period. 93.63% of the stock is currently owned by institutional investors and hedge funds.
Centene Price Performance
Shares of CNC opened at $40.53 on Tuesday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.08. Centene Corporation has a 1-year low of $25.08 and a 1-year high of $66.03. The stock has a market cap of $19.92 billion, a PE ratio of -2.98, a price-to-earnings-growth ratio of 0.90 and a beta of 0.48. The firm has a fifty day moving average price of $42.18 and a 200 day moving average price of $36.55.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on CNC shares. Wells Fargo & Company set a $43.00 price objective on shares of Centene and gave the company an “equal weight” rating in a report on Wednesday, January 7th. Wall Street Zen lowered Centene from a “buy” rating to a “hold” rating in a research report on Sunday. Cantor Fitzgerald reiterated a “neutral” rating and issued a $41.00 target price on shares of Centene in a report on Monday, February 9th. Zacks Research upgraded Centene from a “strong sell” rating to a “hold” rating in a report on Wednesday, October 29th. Finally, Robert W. Baird lifted their price objective on Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, Centene presently has a consensus rating of “Hold” and a consensus target price of $41.81.
View Our Latest Report on Centene
Centene Company Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Featured Stories
- Five stocks we like better than Centene
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
